Admission Date:  [**2119-5-22**]              Discharge Date:   [**2119-5-26**]  Date of Birth:  [**2056-8-7**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Amoxicillin / Zithromax / Clarithromycin / Biaxin / Sulfa (Sulfonamides) / Erythromycin Base / Ofloxacin  Attending:[**First Name3 (LF) 922**] Chief Complaint: Fatigue and dyspnea on exertion  Major Surgical or Invasive Procedure: AVR (#21 CE magna)[**5-22**]   History of Present Illness: 62 year old woman with well known history of Aortic stenosis followed by serial echocardiograms.
no edema or varicosities  Discharge VS T 99.3  HR 74SR  BP 114/64   RR 18  O2sat 98% RA Gen NAD Neuro A&Ox3, nonfocal exam Pulm CTA-bilat CV RRR no murmur Abdm soft, NT/+BS Ext warm, 1+ edema bilat  Pertinent Results: [**2119-5-22**] 11:57AM   GLUCOSE-126* NA+-136 K+-3.2* [**2119-5-22**] 11:48AM   UREA N-14 CREAT-0.6 CHLORIDE-116* TOTAL CO2-21* [**2119-5-22**] 11:48AM   WBC-12.2* RBC-3.07* HGB-9.1* HCT-25.8* MCV-84 MCH-29.6 MCHC-35.3* RDW-13.5 [**2119-5-22**] 11:48AM   PLT COUNT-178 [**2119-5-22**] 11:48AM   PT-15.2* PTT-46.4* INR(PT)-1.3* [**2119-5-26**] 05:25AM BLOOD WBC-8.1 RBC-2.76* Hgb-8.3* Hct-23.3* MCV-85 MCH-30.0 MCHC-35.5* RDW-14.2 Plt Ct-224 [**2119-5-26**] 05:25AM BLOOD Plt Ct-224 [**2119-5-23**] 04:19AM BLOOD PT-13.1 PTT-38.7* INR(PT)-1.1 [**2119-5-26**] 05:25AM BLOOD Glucose-90 UreaN-13 Creat-0.6 Na-142 K-4.0 Cl-102 HCO3-32 AnGap-12  RADIOLOGY  Final Report CHEST (PORTABLE AP)  [**2119-5-25**] 8:18 AM CHEST (PORTABLE AP) Reason: eval for pneumo [**Hospital 93**] MEDICAL CONDITION: 62 year old woman s/p AVR REASON FOR THIS EXAMINATION: eval for pneumo CHEST RADIOGRAPH As compared to the previous radiograph, the lung volumes have bilaterally increased.
DR. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 4130**] Approved: [**Doctor First Name **] [**2119-5-25**] 9:26 AM  [**Hospital1 18**] ECHOCARDIOGRAPHY REPORT [**Known lastname 98982**], [**Known firstname 16235**]       [**Hospital1 18**] [**Numeric Identifier 98983**] (Complete) Done [**2119-5-22**] at 9:00:21 AM      FINAL Referring Physician     [**Name9 (PRE) **] Information [**Name9 (PRE) **], [**First Name3 (LF) 177**] [**Hospital Unit Name 927**] [**Location (un) 86**], [**Numeric Identifier 718**]  Status: Inpatient DOB: [**2056-8-7**] Age (years): 62 F  Hgt (in): BP (mm Hg): /  Wgt (lb): HR (bpm):  BSA (m2): Indication: Aortic valve disease.
Son[**Name (NI) 930**]: [**Initials (NamePattern4) **] [**Last Name (NamePattern4) 6507**], MD Doppler: Full Doppler and color Doppler Test Location: Anesthesia West OR cardiac Contrast: None Tech Quality: Adequate Tape #: 2008AW2-: Machine: Echocardiographic Measurements Results  Measurements  Normal Range Left Ventricle - Septal Wall Thickness:  *0.4 cm  0.6 - 1.1 cm Left Ventricle - Inferolateral Thickness:  *0.4 cm  0.6 - 1.1 cm  Left Ventricle - Diastolic Dimension:  4.3 cm  <= 5.6 cm Left Ventricle - Systolic Dimension:  2.4 cm Left Ventricle - Fractional Shortening:  0.44  >= 0.29 Left Ventricle - Ejection Fraction:  >= 55%  >= 55% Aorta - Annulus:  2.0 cm  <= 3.0 cm Aorta - Sinus Level:  3.3 cm  <= 3.6 cm Aorta - Sinotubular Ridge:  2.4 cm  <= 3.0 cm Aorta - Ascending:  3.0 cm  <= 3.4 cm Aorta - Descending Thoracic:  2.4 cm  <= 2.5 cm Aortic Valve - Peak Velocity:  *4.4 m/sec  <= 2.0 m/sec Aortic Valve - Peak Gradient:  *78 mm Hg  < 20 mm Hg Aortic Valve - Mean Gradient:  48 mm Hg Aortic Valve - Valve Area:  *0.6 cm2  >= 3.0 cm2 Findings Multiplanar reconstructions were generated and confirmed on an independent workstation.
GENERAL COMMENTS: The TEE probe was passed with assistance from the anesthesioology staff using a laryngoscope.
Bioprosthetic valve in the aortic position, Well seated and mechanically stable.
Electronically signed by [**First Name8 (NamePattern2) 6506**] [**Name8 (MD) 6507**], MD, Interpreting physician [**Last Name (NamePattern4) **] [**2119-5-25**] 12:59    Brief Hospital Course: Ms [**Known lastname **] was admitted directly to the operating room on [**5-22**], at that time she had an Aortic valve replaceemnt with a #23 CE magna bioprostetic valve.
She tolerated the operation well and was transferred to the ICU in stable condition.
Once on the floors her activity level was advanced, and medications adjusted.
Medications on Admission: HCTZ 12.5 Q M-W-F Lipitor 20' Levoxyl 75mcg' Lisinopril 5' ASA 81'  Discharge Medications: 1.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Atorvastatin 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Hydromorphone 2 mg Tablet Sig: One (1) Tablet PO q3-4 HRS as needed.
Ferrous Gluconate 325 mg (37.5 mg Iron) Tablet Sig: One (1) Tablet PO DAILY (Daily).
Ascorbic Acid 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Hydrochlorothiazide 12.5 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily).
Take all medications as prescribed.
